Calamine lotion
Available from pharmacies, supermarkets, and retail outlets
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
12 branded products available
MHRA licensed products
View all licensed products for Calamine + Zinc oxide on the MHRA register
Numark Calamine lotion
Calamine lotion
Calamine lotion
Calamine lotion
Calamine lotion
This is the NHS Drug Tariff indicative price used for reimbursement purposes. It may not reflect the price paid by patients or pharmacies.
View full Drug TariffSource: NHS Drug Tariff via NHSBSA. Derived from dm+d VMPP (Virtual Medicinal Product Pack) pricing data. Contains public sector information licensed under the Open Government Licence v3.0.
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 29 · 2014–2024
Showing the 50 most relevant studies, sorted by most relevant.
S. Keerthana, Anoop Kumar
Critical Reviews in Toxicology, 2020
K. Lee, C. Lai, Koh Sing Ngai, et al.
Water research, 2016
Jin-huan Jiang, Jiang Pi, Jiye Cai
Bioinorganic Chemistry and Applications, 2018
H. Agarwal, S. V. Kumar, S. Rajeshkumar
Resource-Efficient Technologies, 2017
K. S. Siddiqi, Aziz Ur Rahman, Tajuddin, et al.
Nanoscale Research Letters, 2018
Hidayat Mohd Yusof, Rosfarizan Mohamad, Uswatun Hasanah Zaidan, et al.
Journal of Animal Science and Biotechnology, 2019
S. Anjum, M. Hashim, Sa Malik, et al.
Cancers, 2021
M. Bandeira, M. Giovanela, M. Roesch-Ely, et al.
Sustainable Chemistry and Pharmacy, 2020
Abstract Zinc oxide is of significant importance for many industries due to its versatile properties, which have been enhanced with the production of this material in the nanoscale. Nonetheless, the increase in concerns related to environmental impact has led to the development of eco-friendly processes for its production. Recent interest in obtaining metal and metal oxide nanoparticles using biological approaches has been reported in the literature. This method was termed ‘green synthesis’ as it is a less hazardous process than chemical and physical synthesis methods currently used in the industry to obtain these nanomaterials. Zinc oxide nanoparticles have been successfully obtained by green synthesis using different biological substrates. However, large scale production using green synthesis approaches remains a challenge due to the complexity of the biological extracts that poses a barrier onto the elucidation of the reactions and mechanism of formation that occur during the synthesis. Hence, the current review includes a summary of the different sources of biological substrates and methodologies applied to the green synthesis of zinc oxide nanoparticles and the impact on their properties. This work also describes the advances on the understanding of the mechanism routes reported in the literature.
Abstract licence: CC BY
Bruna Lallo da Silva, M. P. Abuçafy, Eloísa Berbel Manaia, et al.
International Journal of Nanomedicine, 2019
E. Shaba, J. Jacob, J. Tijani, et al.
Applied Water Science, 2021
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.